New Market Report: Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H2 2013
Global Markets Direct's, 'Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA). Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, Half Year is built using data and information sourced...
View full press release